First-in-class allosteric inhibitors of bacterial IMPDHs - Institut Pasteur Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2019

First-in-class allosteric inhibitors of bacterial IMPDHs


Inosine-5'-monophosphate dehydrogenase (IMPDH) is an essential enzyme in many bacterial pathogens and is considered as a potential drug target for the development of new antibacterial agents. Our recent work has revealed the crucial role of one of the two structural domains (i.e. Bateman domain) in the regulation of the quaternary structure and enzymatic activity of bacterial IMPDHs. Thus, we have screened chemical libraries to search for compounds targeting the Bateman domain and identified first in-class allosteric inhibitors of a bacterial IMPDH. These inhibitors were shown to counteract the activation by the natural positive effector, MgATP, and to block the enzyme in its apo conformation (low affinity for IMP). Our structural studies demonstrate the versatility of the Bateman domain to accommodate totally unrelated chemical scaffolds and pave the way for the development of allosteric inhibitors, an avenue little explored until now.
Fichier principal
Vignette du fichier
1-s2.0-S022352341930084.pdf (23.39 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-02125232 , version 1 (02-03-2021)


Attribution - NonCommercial



Thomas Alexandre, Alexandru Lupan, Olivier Helynck, Sophie Vichier-Guerre, Laurence Dugué, et al.. First-in-class allosteric inhibitors of bacterial IMPDHs. European Journal of Medicinal Chemistry, 2019, 167, pp.124-132. ⟨10.1016/j.ejmech.2019.01.064⟩. ⟨pasteur-02125232⟩
99 View
70 Download



Gmail Facebook Twitter LinkedIn More